Biogen Inc.
NASDAQBIIB heads into its July 29 earnings date swimming against the biotech tide — down nearly 5% on the week while close peers REGN and IONS each rallied more than 7% over the same period. The divergence is notable. Where the broader large-cap biotech group has caught a bid this week, Biogen slipped from roughly $216 to $205.70, giving back a chunk of the 5%…
Snapshot as of 11 Jul 2026
BIIB heads into its July 29 earnings date swimming against the biotech tide — down nearly 5% on the week while close peers REGN and IONS each rallied more than 7% over the same period. The divergence is notable. Where…
BIIB heads into its June 9 earnings print with a notable upgrade landing just hours before the bell, creating a sharp contrast with a defensive options tape and a short book that has grown steadily all month. The…
BIIB pulls back into its June 9 earnings print with the stock softer on the week and short sellers adding positions at a pace that has gone largely unnoticed — the quieter story beneath an otherwise bullish analyst…
BIIB enters its June 9 earnings event with a busier-than-usual week of Street activity — analysts raising targets, a securities fraud investigation making noise in the background, and a pipeline setback still fresh in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BIIB — free to start on ORTEX.
Sign up for free →Open BIIB on ORTEX